LSV Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,768
| Closed | -$29K | – | 880 |
|
|
2023
Q4 | $29K | Hold |
6,768
| – | – | ﹤0.01% | 861 |
|
|
2023
Q3 | $29K | Sell |
6,768
-15,332
| -69% | -$65.7K | ﹤0.01% | 855 |
|
|
2023
Q2 | $146K | Sell |
22,100
-51,100
| -70% | -$338K | ﹤0.01% | 848 |
|
|
2023
Q1 | $497K | Hold |
73,200
| – | – | ﹤0.01% | 736 |
|
|
2022
Q4 | $541K | Hold |
73,200
| – | – | ﹤0.01% | 715 |
|
|
2022
Q3 | $723K | Sell |
73,200
-55,600
| -43% | -$549K | ﹤0.01% | 676 |
|
|
2022
Q2 | $1.4M | Sell |
128,800
-2,136,437
| -94% | -$23.3M | ﹤0.01% | 639 |
|
|
2022
Q1 | $25.6M | Buy |
2,265,237
+4,755
| +0.2% | +$53.8K | 0.05% | 306 |
|
|
2021
Q4 | $35.5M | Buy |
2,260,482
+131,385
| +6% | +$2.06M | 0.06% | 269 |
|
|
2021
Q3 | $36.5M | Buy |
2,129,097
+279,049
| +15% | +$4.78M | 0.07% | 278 |
|
|
2021
Q2 | $39.8M | Buy |
1,850,048
+531,066
| +40% | +$11.4M | 0.07% | 271 |
|
|
2021
Q1 | $19.8M | Buy |
1,318,982
+937,565
| +246% | +$14.1M | 0.03% | 375 |
|
|
2020
Q4 | $5.01M | Buy |
+381,417
| New | +$5.01M | 0.01% | 555 |
|